drugset / Trial / NCT01532141

Effect of Rasagiline on BIA 9-1067 Pharmacokinetics

NCT01532141

Phase 1 Completed 25 enrolled Bial - Portela C S.A.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the effect of rasagiline on BIA 9-1067 pharmacokinetics in healthy subjects.

Timeline

Start
2009-11
Primary completion
2010-02
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Opicapone Small molecule 50 mg
Subject Rasagiline Small molecule 1 mg

Indications